Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

NCT06534723 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Dementia

Interventions

DRUG: Wujia Yizhi granules
DRUG: Placebo

Sponsor

Sichuan Jishengtang Pharmaceutical Co., Ltd.